EUPATI partners with The Organisation for Professionals in Regulatory Affairs (TOPRA)

EUPATI partners with The Organisation for Professionals in Regulatory Affairs (TOPRA) initiating a collaboration on enhancing patient involvement in healthcare regulatory affairs through education.

The European Patients’ Academy of Therapeutic Innovation (EUPATI) is excited to have signed a partnership with The Organisation for Professionals in Regulatory Affairs (TOPRA).  

TOPRA is the global membership organisation for professionals working in healthcare regulatory affairs. Education, co-operation, standard-setting and competence are at the heart of its strategy, and these mirror EUPATI’s goals to educate and train patients and patient representatives to a highly competent level in medicines research and development through a multi-stakeholder environment.  

For EUPATI, this development is particularly important as enhancing involvement of patients across the medicines’ R&D lifecycle – including regulatory affairs – is closely aligned with its mission. There is a continued need to provide education and training for patients and patient representatives from a regulatory perspective and also to increase awareness among the professionals about the importance of patient engagement. This agreement also testifies to TOPRA’s commitment to providing education for its members, and to represent and promote the healthcare regulatory affairs profession globally as a trusted, open and progressive organisation.  

Maria Dutarte, EUPATI Executive Director, noted how: “This newly launched collaboration with TOPRA is significant in many ways and I am confident that this partnership will result in new educational opportunities for both patients and professionals from the regulatory field, bringing about increased awareness of the importance of meaningful patient engagement.”   

Kevin Pay, TOPRA Chief Executive, added: We believe that collaborating with like-minded organisations will amplify our positive impact on healthcare regulatory affairs, and ultimately patient welfare. That is why I am incredibly pleased to announce our partnership with EUPATI, and share my excitement at working with their team on future initiatives that will help us deliver on our shared objectives.” 

TOPRA joins the EUPATI partnership of currently 48 organisations from patient organisations, academia/non-profits and pharmaceutical industry with the mission of providing accessible, innovative and inclusive education that empowers patients and patient representatives with the right knowledge, skills and competencies to effectively engage and partner with all other stakeholders in medicines R&D.  

Related News stories